The U.S. exosomes market was valued at US$ 75.30 million in 2023 and is projected to reach US$ 1,428.79 million by 2033, registering a CAGR of 34.22% from 2024 to 2033. The increasing number of cases of chronic conditions is driving the growth of the U.S. exosomes market.
Download a sample of this report @ https://www.towardshealthcare.com/download-statistics/5158
Key Takeaways
- By product, the kits & reagents segment has held a major revenue share of 46% in 2023.
- By product, the services segment is expected to expand at the fastest CAGR of 33.02% over the forecast period.
- By workflow, the downstream analysis segment held the largest market share in 2023.
- By workflow, the isolation methods segment is anticipated to grow at a significant rate during the forecast period.
- By application, the cancer segment led the market with the largest revenue share of 33% in 2023.
- By application, the infectious diseases segment is projected to grow at the solid CAGR of 35.01% during the forecast period of 2024-2033.
- By end-user, the pharmaceutical & biotechnology companies segment dominated the U.S. exosomes market in 2023.
Industry at a Glance
The U.S. exosomes market is expanding because of the increasing use of exosomes in diagnosing and treating various diseases and health conditions. Exosomes belong to a group of extracellular vesicles that come from the endosomal system and usually measure between 30 to 150 nanometers in size, making them the smallest kind of extracellular vesicle. These vesicles are surrounded by a lipid bilayer and are released into the surrounding space, carrying a mix of complex materials from the cell they originated from, such as proteins, lipids, mRNA, miRNA, and DNA. They serve the function of transporting and exchanging different substances between cells and are utilized as non-invasive indicators for various diseases.
Top Companies in the U.S. Exosomes Market
- Aethlon Medical
- Aegle Therapeutics Corporation
- Coya Therapeutics
- Capricor Therapeutics
- Aragen Bioscience
- RoosterBio, Inc
- Bio-Techne
- Hologic Inc.
- Thermo Fisher Scientific, Inc.
- Celularity Inc.
- Danaher
Celularity Inc. Pipeline in Exosomes Application
| Company Name | Celularity Inc. |
| Headquarters | New Jersey, U.S. |
| Pipeline | The firm is working on creating placental exosomes (pExo) as possible therapies that can transport growth-promoting factors, aiding in the formation of neural cells, blood vessels, and muscle tissue. pExo shows specific markers for exosomes, such as CD9, CD63, and CD81, and holds more than a thousand unique proteins and microRNAs that play roles in various biological processes. pExo includes various types of cytokines and chemokines and helps grow primary human cells from various organs and tissues. The pExo pipeline is currently being assessed for potential uses in treating regenerative and age-related conditions at the pre-clinical level. |
Aethlon Medical Pipeline in Exosomes Application
| Company Name | Aethlon Medical |
| Headquarters | California, U.S. |
| Pipeline | In May 2024, the company announced the positive results of the phase I trial of Hemopurifier®. It will now move to the next stage. Designed to quickly reduce circulating viruses and exosomes that promote cancer, the Aethlon Hemopurifier® is a pioneering technology. The Hemopurifier® is a “Breakthrough Device” according to the FDA, meaning that it can be used to treat patients with life-threatening viruses that are not treated by approved therapies, as well as patients with advanced or metastatic cancer who are either intolerant of or unresponsive to standard-of-care therapy. |
The Different Applications of Exosomes are Driving the Growth of the U.S. Exosomes Market
Exosomes are vesicles released from cells that are crucial for communication between cells and are found in many bodily fluids such as blood, saliva, urine, and cerebrospinal fluid, among others. Exosomes are evidently occurring compounds that may withstand digestive enzymes because of the innate residences of exosomes, including their capability tissue of mobile selectivity. The capability to go blood-mind barriers causes fewer systemic consequences and occasional toxicity. These vesicles are particularly well-suited for cancer detection due to their distinct features. They are also valuable in predicting and identifying a range of illnesses, including cancer, heart and age-related diseases, arthritis, brain disorders, and diabetes.
Additionally, exosomes are utilized in medical research and early-stage clinical studies. In recent years, cures using extracellular vesicles have garnered substantial attention among industry stakeholders to remedy numerous target warning signs, generally owing to their numerous applications, including goal specificity, more advantageous tissue regeneration, and reduced irritation and chronic pain.
Segments Covered in the Report
By Product Type
- Kits & Reagents
- Instruments
- Services
By Workflow Type
- Isolation Methods
- Ultracentrifugation
- Immunocapture on Beads
- Precipitation
- Filtration
- Others
- Downstream Analysis
- Cell Surface Marker Analysis using Flow Cytometry
- Protein Analysis using Blotting & ELISA
- RNA Analysis with NGS & PCR
- Proteomic Analysis using Mass Spectroscopy
- Others
By Application Type
- Cancer
- Neurodegenerative Diseases
- Cardiovascular Diseases
- Infectious Diseases
- Others
By End-use Type
- Pharmaceutical & Biotechnology Companies
- Hospitals & Diagnostics Centers
- Academic & Research Institutes
Discover our detailed Table of Contents (TOC) for the Industry, providing a thorough examination of market segments, material, emerging technologies and key trends. Our TOC offers a structured analysis of market dynamics, emerging innovations, and regional dynamics to guide your strategic decisions in this rapidly evolving healthcare field – https://www.towardshealthcare.com/table-of-content/us-exosomes-market-sizing
To own our research study instantly, Click here @ https://www.towardshealthcare.com/price/5158
You can place an order or ask any questions, please feel free to contact us at sales@towardshealthcare.com
About Us
Towards Healthcare is a leading global provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations. We are a global strategy consulting firm that assists business leaders in gaining a competitive edge and accelerating growth. We are a provider of technological solutions, clinical research services, and advanced analytics to the healthcare sector, committed to forming creative connections that result in actionable insights and creative innovations.
Explore the comprehensive statistics and insights on healthcare industry data and its associated segmentation: Get a Subscription
For Latest Update Follow Us: https://www.linkedin.com/company/towards-healthcare